422 related articles for article (PubMed ID: 32758336)
21. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
Escobar LE; Molina-Cruz A; Barillas-Mury C
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17720-17726. PubMed ID: 32647056
[TBL] [Abstract][Full Text] [Related]
22. The bacillus Calmette-Guérin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
Patella V; Delfino G; Bruzzese D; Giuliano A; Sanduzzi A
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25205-25206. PubMed ID: 32994349
[No Abstract] [Full Text] [Related]
23. COVID-19 and Bacillus Calmette-Guérin: What is the Link?
Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM
Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396
[TBL] [Abstract][Full Text] [Related]
24. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
[TBL] [Abstract][Full Text] [Related]
25. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
27. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data.
Wassenaar TM; Buzard GS; Newman DJ
Lett Appl Microbiol; 2020 Nov; 71(5):498-505. PubMed ID: 32734625
[TBL] [Abstract][Full Text] [Related]
28. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
[TBL] [Abstract][Full Text] [Related]
29. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Faustman DL; Wang L; Okubo Y; Burger D; Ban L; Man G; Zheng H; Schoenfeld D; Pompei R; Avruch J; Nathan DM
PLoS One; 2012; 7(8):e41756. PubMed ID: 22905105
[TBL] [Abstract][Full Text] [Related]
30. Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19.
Berg MK; Yu Q; Salvador CE; Melani I; Kitayama S
Sci Adv; 2020 Aug; 6(32):eabc1463. PubMed ID: 32923613
[TBL] [Abstract][Full Text] [Related]
31. Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
Kumar A; Misra S; Verma V; Vishwakarma RK; Kamal VK; Nath M; Prakash K; Upadhyay AD; Sahu JK
PLoS One; 2020; 15(10):e0240710. PubMed ID: 33091086
[TBL] [Abstract][Full Text] [Related]
32. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
33. A case series of bacillus Calmette-Guérin scar reactivation after administration of both mRNA and viral vector COVID-19 vaccines.
van Balveren L; van Puijenbroek EP; Davidson L; van Hunsel F
Br J Clin Pharmacol; 2023 Jul; 89(7):2113-2121. PubMed ID: 36717367
[TBL] [Abstract][Full Text] [Related]
34. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
Kumari P; Gupta UD; Bhagyawant SS
Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
[TBL] [Abstract][Full Text] [Related]
35. BCG epidemiology supports its protection against COVID-19? A word of caution.
Szigeti R; Kellermayer D; Trakimas G; Kellermayer R
PLoS One; 2020; 15(10):e0240203. PubMed ID: 33027297
[TBL] [Abstract][Full Text] [Related]
36. Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guérin (BCG) vaccination on COVID-19 prevalence and mortality.
Barillas-Mury C; Escobar LE; Molina-Cruz A
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25207-25208. PubMed ID: 32994348
[No Abstract] [Full Text] [Related]
37. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
You NN; Liu Q; Zhu LM; Lu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
[TBL] [Abstract][Full Text] [Related]
38. Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.
Osama El-Gendy A; Saeed H; Ali AMA; Zawbaa HM; Gomaa D; Harb HS; Madney YM; Osama H; Abdelrahman MA; Abdelrahim MEA
Vaccine; 2020 Jul; 38(35):5564-5568. PubMed ID: 32654907
[TBL] [Abstract][Full Text] [Related]
39. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
40. BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check.
Pandita A; Bhat A; Koul A; Singh SK
Curr Pharm Biotechnol; 2021; 22(12):1574-1583. PubMed ID: 33530904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
